Resumen
La neurocisticercosis es una enfermedad parasitaria que ocurre por la infección del estado larvario de la Taenia solium
en el sistema nervioso central (SNC). Es una de las patologías más encontradas en los servicios neuroquirúrgicos de
los países latinoamericanos. La neurocisticercosis es la causa de convulsión más frecuente en esta región del mundo.
Esta enfermedad se clasifica en distintos síndromes dependiendo de su localización y clínica: en neurocisticercosis
parenquimatosa, ventricular, espinal y ocular. La sintomatología también es variada siendo las convulsiones su
manifestación más frecuente seguida de cefaleas, déficit neurológico focal, demencia y psicosis. Debido al polimorfismo
clínico de la enfermedad, no es posible que un único esquema de tratamiento sea eficaz en todos los casos, por lo tanto,
su caracterización, en lo que respecta a la viabilidad y localización de los parásitos, es fundamental para planificar el
tratamiento adecuado. Este es un articulo de revisión sobre la neurocisticercosis con enfoque desde el punto de vista
neurológico y neuroquirúrgico, en el diagnostico y el manejo de esta enfermedad.
Citas
Del Brutto O. H. Neurocisticercosis. Rev Neurol 1999;29: 456-466
Clinton W. Neurocysticercosis: Updates on Epidemiology, Pathogenesis, Diagnosis, and Management. Ann. Rev. Med 2000;51:187-206.
Garcia H, Martinez M, Gilman R, et al. Diagnosis of cysticercosis in endemic regions. The Lancet 1991;31: 549-551.
Mitre E, Geltman P, Meyers A, Pallin DJ, Muennig PA. Treatment of Intestinal Parasites in Immigrants. N Engl J Med 1999;341:377.
Richards FO Jr, Schantz PM, Ruiz-Tiben E, et al: Cysticercosis in Los Angeles County. JAMA 1985;254:3444-3448.
Firemark HM. Spinal cysticercosis. Arch Neurol 1978;35:250-251.
Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int. 2006;55(suppl):S111-S115.
Rajshekhar V, Joshi DD, Doanh NQ, et al. Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop. 2003;87:53-60.
Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004;63: 1559-1564.
Garcia HH, Del Brutto OH. Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005;4:653-661.
Pittella JEH: Neurocysticercosis. Brain Pathol 1997;7:681-693.
Mamkin I, Sood N, Ramanan SV. Taenia solium neurocysticercosis. N Engl J Med 2007;357(16):1666-1667.
Willms K. Morphology and biochemistry of the pork tapeworm, Taenia solium. Curr Top Med Chem 2008;8(5):375-82.
Garg RK. Neurocysticercosis: A Pictorial Review.
Infectious Diseases in Clinical Practice 2008;16:4:210-217.
García HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000;14:97-119.
Del Brutto OH, Rajshekhar V, White AC Jr. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.
Sanchez AL, Lindback J, Schantz PM, et al: A populationbased,case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999;93:247-258.
Sanchez AL, Ljungstrom I, Medina MT: Diagnosis of human neurocysticerocosis in endemic countries: a clinical study in Honduras. Parasitol Int 1999;48:81-89.
Sotelo J, del Brutto OH. Review of neurocysticercosis.
Neurosurg Focus 2002;12:6:1-7.
Escobar A, Nieto D. Parasitic diseases, in Minckler J (ed). Pathology of the Nervous System, Volume 3. New York: Mc-Graw-Hill, 1972, pp 2503-2521.
Garg RK. Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol India. 2004;52:171-177.
Flisser A. Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol 1994;4:77-116.
do Amaral LL, Ferreira RM, da Rocha AJ, et al. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging. 2005;16:127-144.
Del Brutto OH, Santibanez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-392.
Torres-Corzo J, Rodriguez-della Vecchia R, Rangel- Castilla L. Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg. 2006;104:746-748.
Zenteno-Alinis GH. A classification of human cysticercosis, in Flisser A, Willms K, Laclette JP, et al (eds): Cysticercosis: Present State of Knowledge and Perspectives: Proceedings of an International Workshop on Cysticercosis Held in San Miguel de Allende, Guanajuato, Mexico, on November 16-18, 1981. New York: Academic Press, 1982, pp 107-126.
Citow JS, Johnson JP, McBride DQ, Ammirati
M. Imaging features and surgery-related outcomes in intraventricular neurocysticercosis. Neurosurg Focus 2002; 6:Article 6:1-12.
Lopez-Hernandez A, Garaizar C: Childhood cerebral cysticercosis:clinical factors and computed tomographic finding in 89Mexican children. Can J Neurol Sci 1982;9:401-407.
Akiguchi I, Fujiwara T, Matsuyama H, Muranaka H, Kameyama M. Intramedullary spinal neurocysticercosis. Neurology 1979;29:1531-1534.
Colli BO, Valenc$a MM, Carlotti CG Jr, et al. Spinal cord cysticercosis: neurosurgical aspects. Neurosurg Focus. 2002;12:e9.
Paterakis KN, Kapsalaki E, Hadjigeorgiou GM, et al. Primary spinal intradural extramedullary cysticercosis. Surg Neurol. 2007;68:309-311.
Wadia N, Desai S, Bhatt M. Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111:597-614.
Pal DK, Carpio A, Sander J. Neurocysticercosis and epilepsy in developing Countries. J Neurol Neurosurg Psychiatry 2000;68:137-143.
Wadia NH. Neurocysticercosis. In: Shakir RA, Newman PK, Poser CM, eds. Tropical neurology. London: Saunders, 1996:247-273.
White AC. Neurocysticercosis: a major cause of neurologicaldisease worldwide. Clin Infect Dis 1997;24:101-115.
Monteiro L, Nunes B, Mendonca D, et al. Spectrum of epilepsy in neurocysticercosis: a long term follow-up of 143 patients. Acta Neurol Scand 1995;92:33-40.
Powell SY, Proctor AJ, Wilmot B, et al. Cysticercosis and epilepsy in Africans: a clinical and neurological study. Ann Trop Med Parasitol 1966;60:142-58.
Forlenza OV, Filho AHGV, Nobrega JPS, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 1997;62:612-616.
Del Brutto OH, Guevara J, Sotelo J. Intrasellar cysticercosis. J Neurosurg 1998;69:58-60.
Martinez HR, Rangel-Guerra R, Elizondo G, et al. MR imaging in neurocysticercosis: a study of 56 cases. AJNR 1989;10:1011-1019.
Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR 1986;7:235-242.
Salgado P, Rojas R, Sotelo J. Cysticercosis. Clinical classification based on imaging studies. Arch Intern Med 1997;157:1991-1997.
Bandres JC, White AC Jr, Samo T, et al. Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis 1992 15:799-811.
Ginier BL, Poirier VC. MR imaging of intraventricular cysticercosis. AJNR 1992 13:1247-1248.
Madrazo I, Renteria JAC, Paredes G, et al. Diagnosis of intraventricular and cisternal cysticercosis by computerized tomography with positive intraventricular contrast medium. J Neurosurg 1981;55:947-951.
Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop 2003;87:71-78.
Dorny P, Brandt J, Zoli A, et al. Immunodiagnostic tools for human and porcine cysticercosis. Acta Trop 2003;87:79-86.
Del Brutto OH, Roos KL, Coffey CS, et al. Meta- analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51.
Del Brutto OH, Sotelo J, Roman GC. Therapy for neurocysticercosis: a reappraisal. Clin Infec Dis 1993;17:730-735.
Corona T, Lugo R, Medina R, et al. Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 1996;334:125.
Del Brutto OH, Campos X, Sánchez J, et al. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 1999;52:1079-1081.
López-Gómez M, Castro N, Jung H, et al. Optimization of the single-day praziquantel therapy for neurocysticercosis.
Neurology 2001;57;1929-1930.
Pretell EJ, García HH, Custodio N, et al. Short regimen of praziquantel in the treatment of single brain enhancing lesions. Clin Neurol Neurosurg 2000;102:215-218.
Sotelo J, Escobedo F, Rodriguez-Carbajal J, et al. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310:1001-1007.
Sotelo J, Torres B, Rubio-Donnadieu F, et al. Praziquantel in the treatment of neurocysticercosis: a long-term follow-up. Neurology 1985;35:752-755.
García HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 1997;48:1421-1427.
Sotelo J, del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990;237:69-72.
Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-294.
Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1997;62:659-661.
Suastegui Roman RA, Soto-Hernández JL, Sotelo
J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 1996;84:629-633.
Flisser A, Sarti E, Lightowlers M, et al. Neurocysticercosis. regional status, epidemiology, impact and control measures in the Americas. Acta Trop 2003;87:43-51.
Zee CS, Segall HD, Apuzzo MLJ, et al. Intraventricular cysticercal cysts: further neuroradiologic observations and neurosurgical implications. AJNR 1984;5:727-730.
Kaliaperumal S, Rao VA, Parija SC. Cysticercosis of the eye in South IndiaVa case series. Indian J Med Microbiol 2005;23:227-230.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.